| 000 | 01006 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513024330.0 | ||
| 264 | 0 | _c19810129 | |
| 008 | 198101s 0 0 ita d | ||
| 022 | _a0026-4806 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMolinatti, G M | |
| 245 | 0 | 0 |
_a[Can the anti-androgenic effect of spironolactone contraindicate its use in pregnancy?]. _h[electronic resource] |
| 260 |
_bMinerva medica _cOct 1980 |
||
| 300 |
_a2801-2 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAbnormalities, Drug-Induced _xetiology |
| 650 | 0 | 4 | _aAndrogen Antagonists |
| 650 | 0 | 4 |
_aAndrogens _xbiosynthesis |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFetus _xdrug effects |
| 650 | 0 | 4 |
_aGenitalia, Male _xabnormalities |
| 650 | 0 | 4 |
_aHirsutism _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aSpironolactone _xadverse effects |
| 773 | 0 |
_tMinerva medica _gvol. 71 _gno. 39 _gp. 2801-2 |
|
| 999 |
_c7432186 _d7432186 |
||